Trade Mark Journal No.2025/022 30 May 2025

WO0000001853121 (5,44)

Office of origin: United States of America

Date of International Registration:17 December 2024
Date of designation in the UK: 17 December 2024
Image for mark 1853121

The mark consists of a geometric design consisting of five fanned out triangular shapes sharing a common center and of gradient shades and angles with the leftmost shape in the darkest shade, pointed at a 145 degree angle, and featuring a rounded bottom with a hole in the center and the rightmost shape being the lightest shade and at a 0 degree angle. To the right of the design is the stylized wording "METAVIA" with "META" in a darker shade than "VIA".

International priority date claimed: 29 October 2024 (United States of America) (98825467)
Class 5
Pharmaceutical preparations for the treatment of liver diseases and disorders and metabolic disorders; pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for the treatment of obesity.
Class 44
Providing medical information in the fields of pharmaceuticals and medicines; providing information in the fields of healthcare, health conditions, health awareness and treatment options; medical information services, namely, providing information related to healthcare, diseases and disorders, and treatment options; online information services, namely, providing information related to healthcare, health awareness, medical aspect of medicines, diseases and disorders, and treatment options via a website.

METAVIA INC.

Representative: Rachel M. Hofstatter Honigman LLP, 39400 Woodward Avenue, Suite 101, Bloomfield Hills MI 48304-5151, UNITED STATES OF AMERICA